Company intelligence / Profile preview

Finox Biotech

Ownership: Private
Development stage: Commercial

Overview

Finox Biotech was a Swiss biotech company specializing in the development and commercialization of biosimilar fertility drugs combined with patient-friendly injection devices. Its lead product Bemfola®, a biosimilar recombinant human follicle stimulating hormone (r-hFSH), received EU marketing authorization in May 2014 and achieved significant market share across Europe, Israel, Middle East, and Australia before being acquired by Gedeon Richter Plc. The company’s approach emphasized cost-effective therapies for female fertility using innovative delivery systems.

Therapeutic areas: OtherWomen's Health
Modalities: Biosimilars (notably recombinant proteins)Recombinant polypeptidesSmall molecules (less prominent)
Industry: Biotech

Drug pipeline

1 asset

bemfola

Commercial

Indications: Female infertility

Partnerships

Genpharm Services—commercialization agreement for MENA region signed September 2014

Beyond the preview

Go deeper on Finox Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Finox Biotech.

Explore the full profile